Table 4C.

	Carcinoma in Situ Response
Study ID	Complete response						Partial response no Cis, but Ta/T1 persists	No change Cis or Ta/T1 persists
	No Cis, no Ta/T1	at 9 mo no progression; at 12 mo no recurrence	Complete response in cis patients	Time to recurrence in complete responders	Recurrence after complete response	First recurrence type after complete response (papillary, cis, papillary + cis)
Lamm 2000			x	x
Palou 2001
Au 2001
Sekine 2001			x		x
Martinez-Pinneiro 2002
Di Stasi 2003	x
Kaasinen 2003		x
Martinez-Pinneiro 2005
de Reijke 2005	x			x		x	x
di Stasi 2006	x
Gårdmark 2007
Cai 2008	x
Neple 2010
Porena 2010
Koga 2010	x
Gülpınar 2012
Järvinen 2012
Sengiku 2013			x
Inamoto 2013
Rentsch 2014
Hemdan 2014
Martinez-Pineiro 2015
Solsona 2015
Arends 2016			x
Nakai 2016